From today, the Australian government will expand Pharmaceutical Benefit Scheme (PBS) access to the drug Keytruda for three ...
A new data cut of a trial pitting ivonescimab, a bispecific antibody, against Merck’s Keytruda showed the new drug helped ...
Hosted on MSN
Oncologists explain why they prescribe Keytruda to cancer patients, when and how it works
Keytruda is an immunotherapy drug that is prescribed to cancer patients and is used to treat different types of cancer. It was first approved by the FDA in 2014 for the treatment of advanced or ...
ASCENT-04 randomized PD-L1–positive, untreated mTNBC to sacituzumab govitecan–pembrolizumab versus chemo–pembrolizumab, yielding a 3.4-month median PFS improvement (HR 0.65). Front-loading an ...
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug Summit Therapeutics and Akeso shared more data for their experimental lung-cancer drug ...
The personalized cancer vaccine being developed by Moderna and Merck has boosted hopes that mRNA technology could open up a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results